Latest Vascular Solutions (VASC) Headlines Phys
Post# of 21
Posted On: 03/13/2014 3:24:29 PM
Latest Vascular Solutions (VASC) Headlines
Physician Reports Positive 12-Month Clinical Experience and Cost Savings From Use of Reprocessed ClosureFAST(R) Catheters
GlobeNewswire - Wed Feb 19, 3:30PM CST
-- Dr. James Isobe presented data today at the American Venous Forum annual meeting in New Orleans reflecting his experience using Vascular Solutions' reprocessing service for ClosureFAST catheters.
8-K: VASCULAR SOLUTIONS INC
Edgar Online - Tue Feb 04, 11:07PM CST
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Vascular Solutions Reports Record Fourth Quarter Results
GlobeNewswire - Tue Feb 04, 9:49PM CST
-- Q4 revenue increased 15% to a record quarterly level of $29.1 million, exceeding the top end of guidance
Vascular Solutions Launches ThrombiDisc(TM) Topical Hemostat in U.S.
GlobeNewswire - Tue Jan 21, 8:00AM CST
- Novel thrombin-based topical hemostat controls bleeding from vascular access sites
Teekay Offshore Completes Norwegian Bond Issuance
Marketwire Canada - Tue Jan 14, 9:09AM CST
Teekay Offshore Partners L.P. (Teekay Offshore or the Partnership) (NYSE:TOO) announces that it has issued NOK 1,000 million in senior unsecured bonds, maturing in January 2019, in the Norwegian bond market. The aggregate principal amount of the bonds is equivalent to approximately 165 million U.S. dollars (USD). The bond offering was significantly oversubscribed. The proceeds of the bonds are expected to be used for general partnership purposes. Teekay Offshore will apply for listing of the bonds on the Oslo Stock Exchange.
Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Becomes Effective
GlobeNewswire - Mon Jan 13, 8:03AM CST
Vascular Solutions, Inc. (Nasdaq:VASC) announced today that the U.S. Court of Appeals for the Federal Circuit has refused to grant an interim stay during appeal of the injunction issued by the District Court for the District of Minnesota against Boston Scientific's Guidezilla guide extension catheter, thereby causing the injunction to take effect starting January 13, 2014.
Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call
GlobeNewswire - Tue Jan 07, 3:05PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its fourth quarter conference call on Tuesday, February 4th at 3:30pm CST. Vascular Solutions' Chief Executive Officer, Howard Root, Chief Financial Officer, James Hennen and VP of Corporate Development, Phil Nalbone, will discuss the company's fourth quarter results. The company will issue an earnings news release after market close on Tuesday, February 4th.
Vascular Solutions Receives Shonin Approvals to Launch GuideLiner(R) Catheter and SuperCross(TM) FT Microcatheter in Japan
GlobeNewswire - Wed Dec 11, 3:05PM CST
-- Both devices also receive reimbursement designation from the Japanese Ministry of Health, Labour and Welfare
Vascular Solutions Granted Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter
GlobeNewswire - Mon Dec 09, 5:02PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) announced today that the U.S. District Court for the District of Minnesota has granted Vascular Solutions' request for a preliminary injunction against Boston Scientific's Guidezilla guide extension catheter.
Shares of VASC Up 33.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 29, 9:32AM CST
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on July 16th, 2013 at $15.81. In approximately 5 months, Vascular Solutions has returned 33.82% as of today's recent price of $21.15.
Vascular Solutions to Present at the 25th Annual Piper Jaffray Health Care Conference
GlobeNewswire - Tue Nov 26, 3:05PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 25 Annual Piper Jaffray Health Care Conference in New York City on Wednesday, December 4 at 12:00pm (EST).
Vascular Solutions Shares Up 30.8% Since SmarTrend's Buy Recommendation (VASC)
Comtex SmarTrend(R) - Wed Nov 13, 4:52PM CST
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on July 16th, 2013 at $15.81. In approximately 4 months, Vascular Solutions has returned 30.84% as of today's recent price of $20.68.
ITGI Signs Strategic Cooperation Agreement with Vascular Solutions to Commercialize ITGI's Coronary Covered Stent in the U.S. Market
Business Wire - Mon Nov 11, 8:00AM CST
--Vascular Solutions will serve as exclusive U.S. distributor of ITGI's novel pericardium-covered stent, targeting use in emergency interventions in native coronary arteries, aneurysms and diseased saphenous vein grafts.
20.1% Return Seen to Date on SmarTrend Vascular Solutions Call (VASC)
Comtex SmarTrend(R) - Wed Nov 06, 11:03AM CST
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on July 16th, 2013 at $15.81. In approximately 4 months, Vascular Solutions has returned 20.09% as of today's recent price of $18.98.
Vascular Solutions to Present at the Barclays Select Growth Conference
GlobeNewswire - Mon Nov 04, 3:05PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the Barclays Select Growth Conference in New York City on Monday, November 18 at 2:50pm (EDT).
Atherectomy and Thrombectomy Devices Worldwide Market Report - with Forecast to 2016
M2 - Mon Nov 04, 4:41AM CST
Research and Markets (http://www.researchandmarkets.com/research/7c6cg7/global) has announced the addition of the "Atherectomy and Thrombectomy Devices Worldwide Market Report - with Forecast to 2016" report to their offering. Analysts forecast the Global Atherectomy Devices market to grow at a CAGR of 11.48 percent and the Global Thrombectomy Devices market to grow at a CAGR of 8.14 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of Abdominal Aortic Aneurysm and Peripheral Arterial Disease worldwide. The Global Atherectomy and Thrombectomy Devices market has also been witnessing an increase in patent grants and US FDA approvals. Key questions answered in this report: - What will the market size be in 2016 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of each of these key vendors? Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Rate of Incidence and Prevalence 10. Vendor Landscape 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Key Vendor Analysis 18. Other Reports in this Series Companies Mentioned - Bayer AG - Boston Scientific Corp. - Covidien plc - Getinge AB - Spectranetics Corp. - Straub Medical AG - Vascular Solutions Inc. - 3M Co. - American Heart Association Inc. - Aerotel Medical Systems Ltd. - Asian Heart Institute - Cook Medical Inc. - ev3 Inc. - Heartware International Ltd. - Nihon Kohden Corp. - Smith & Nephew plc - Sorin Group USA Inc. - St. Jude Medical Inc. - Terumo Medical Corp. - Ventracor Ltd. - Uscom Ltd. - Zoll Medical Corp. For more information visit http://www.researchandmarkets.com/research/7c6cg7/global
Vascular Solutions to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
GlobeNewswire - Wed Oct 30, 3:05PM CDT
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the Canaccord Genuity Medical Technology and Diagnostics Forum in New York City on Thursday, November 14 at 8:30am (EST).
Physician Reports Positive 12-Month Clinical Experience and Cost Savings From Use of Reprocessed ClosureFAST(R) Catheters
GlobeNewswire - Wed Feb 19, 3:30PM CST
-- Dr. James Isobe presented data today at the American Venous Forum annual meeting in New Orleans reflecting his experience using Vascular Solutions' reprocessing service for ClosureFAST catheters.
8-K: VASCULAR SOLUTIONS INC
Edgar Online - Tue Feb 04, 11:07PM CST
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Vascular Solutions Reports Record Fourth Quarter Results
GlobeNewswire - Tue Feb 04, 9:49PM CST
-- Q4 revenue increased 15% to a record quarterly level of $29.1 million, exceeding the top end of guidance
Vascular Solutions Launches ThrombiDisc(TM) Topical Hemostat in U.S.
GlobeNewswire - Tue Jan 21, 8:00AM CST
- Novel thrombin-based topical hemostat controls bleeding from vascular access sites
Teekay Offshore Completes Norwegian Bond Issuance
Marketwire Canada - Tue Jan 14, 9:09AM CST
Teekay Offshore Partners L.P. (Teekay Offshore or the Partnership) (NYSE:TOO) announces that it has issued NOK 1,000 million in senior unsecured bonds, maturing in January 2019, in the Norwegian bond market. The aggregate principal amount of the bonds is equivalent to approximately 165 million U.S. dollars (USD). The bond offering was significantly oversubscribed. The proceeds of the bonds are expected to be used for general partnership purposes. Teekay Offshore will apply for listing of the bonds on the Oslo Stock Exchange.
Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Becomes Effective
GlobeNewswire - Mon Jan 13, 8:03AM CST
Vascular Solutions, Inc. (Nasdaq:VASC) announced today that the U.S. Court of Appeals for the Federal Circuit has refused to grant an interim stay during appeal of the injunction issued by the District Court for the District of Minnesota against Boston Scientific's Guidezilla guide extension catheter, thereby causing the injunction to take effect starting January 13, 2014.
Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call
GlobeNewswire - Tue Jan 07, 3:05PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its fourth quarter conference call on Tuesday, February 4th at 3:30pm CST. Vascular Solutions' Chief Executive Officer, Howard Root, Chief Financial Officer, James Hennen and VP of Corporate Development, Phil Nalbone, will discuss the company's fourth quarter results. The company will issue an earnings news release after market close on Tuesday, February 4th.
Vascular Solutions Receives Shonin Approvals to Launch GuideLiner(R) Catheter and SuperCross(TM) FT Microcatheter in Japan
GlobeNewswire - Wed Dec 11, 3:05PM CST
-- Both devices also receive reimbursement designation from the Japanese Ministry of Health, Labour and Welfare
Vascular Solutions Granted Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter
GlobeNewswire - Mon Dec 09, 5:02PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) announced today that the U.S. District Court for the District of Minnesota has granted Vascular Solutions' request for a preliminary injunction against Boston Scientific's Guidezilla guide extension catheter.
Shares of VASC Up 33.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 29, 9:32AM CST
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on July 16th, 2013 at $15.81. In approximately 5 months, Vascular Solutions has returned 33.82% as of today's recent price of $21.15.
Vascular Solutions to Present at the 25th Annual Piper Jaffray Health Care Conference
GlobeNewswire - Tue Nov 26, 3:05PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 25 Annual Piper Jaffray Health Care Conference in New York City on Wednesday, December 4 at 12:00pm (EST).
Vascular Solutions Shares Up 30.8% Since SmarTrend's Buy Recommendation (VASC)
Comtex SmarTrend(R) - Wed Nov 13, 4:52PM CST
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on July 16th, 2013 at $15.81. In approximately 4 months, Vascular Solutions has returned 30.84% as of today's recent price of $20.68.
ITGI Signs Strategic Cooperation Agreement with Vascular Solutions to Commercialize ITGI's Coronary Covered Stent in the U.S. Market
Business Wire - Mon Nov 11, 8:00AM CST
--Vascular Solutions will serve as exclusive U.S. distributor of ITGI's novel pericardium-covered stent, targeting use in emergency interventions in native coronary arteries, aneurysms and diseased saphenous vein grafts.
20.1% Return Seen to Date on SmarTrend Vascular Solutions Call (VASC)
Comtex SmarTrend(R) - Wed Nov 06, 11:03AM CST
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on July 16th, 2013 at $15.81. In approximately 4 months, Vascular Solutions has returned 20.09% as of today's recent price of $18.98.
Vascular Solutions to Present at the Barclays Select Growth Conference
GlobeNewswire - Mon Nov 04, 3:05PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the Barclays Select Growth Conference in New York City on Monday, November 18 at 2:50pm (EDT).
Atherectomy and Thrombectomy Devices Worldwide Market Report - with Forecast to 2016
M2 - Mon Nov 04, 4:41AM CST
Research and Markets (http://www.researchandmarkets.com/research/7c6cg7/global) has announced the addition of the "Atherectomy and Thrombectomy Devices Worldwide Market Report - with Forecast to 2016" report to their offering. Analysts forecast the Global Atherectomy Devices market to grow at a CAGR of 11.48 percent and the Global Thrombectomy Devices market to grow at a CAGR of 8.14 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of Abdominal Aortic Aneurysm and Peripheral Arterial Disease worldwide. The Global Atherectomy and Thrombectomy Devices market has also been witnessing an increase in patent grants and US FDA approvals. Key questions answered in this report: - What will the market size be in 2016 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of each of these key vendors? Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Rate of Incidence and Prevalence 10. Vendor Landscape 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Key Vendor Analysis 18. Other Reports in this Series Companies Mentioned - Bayer AG - Boston Scientific Corp. - Covidien plc - Getinge AB - Spectranetics Corp. - Straub Medical AG - Vascular Solutions Inc. - 3M Co. - American Heart Association Inc. - Aerotel Medical Systems Ltd. - Asian Heart Institute - Cook Medical Inc. - ev3 Inc. - Heartware International Ltd. - Nihon Kohden Corp. - Smith & Nephew plc - Sorin Group USA Inc. - St. Jude Medical Inc. - Terumo Medical Corp. - Ventracor Ltd. - Uscom Ltd. - Zoll Medical Corp. For more information visit http://www.researchandmarkets.com/research/7c6cg7/global
Vascular Solutions to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
GlobeNewswire - Wed Oct 30, 3:05PM CDT
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the Canaccord Genuity Medical Technology and Diagnostics Forum in New York City on Thursday, November 14 at 8:30am (EST).
(0)
(0)Vascular Solutions (VASC) Stock Research Links
Scroll down for more posts ▼